Literature DB >> 29071539

Knockdown of IARS2 suppressed growth of gastric cancer cells by regulating the phosphorylation of cell cycle-related proteins.

Zheng Fang1, Xingyu Wang1, Qiang Yan2, Shangxin Zhang2, Yongxiang Li3.   

Abstract

The purpose of the article is to investigate the role of IARS2 in proliferation, apoptosis, and cell cycle of gastric cancer (GC) cells in vitro. The IARS2-shRNA lentiviral vector was established and used to infect the GC cell line AGS. qRT-PCR and Western blot were employed to determine the efficiency of IARS2 knockdown. The effects of IARS2 knockdown on cell proliferation, cell clone formation, and cell cycle were assessed by MTT assay, colony formation assay, and flow cytometer analysis, respectively. Finally, a PathScan Antibody Array Kit was used to detect the expression levels of cell cycle-related proteins after IARS2 knockdown in AGS cells to elucidate the underlying mechanisms. Compared with negative control group, IARS2 was significantly knocked down by transfection with lentivirus encoding shRNA of IARS2 in AGS cells. IARS2 knockdown significantly inhibited the proliferation and colony formation ability and induced cycle arrest at G2/M phase of AGS cells. IARS2 knockdown significantly decreased the expression levels of phosphorylation of (p-Smad2), p-SAPK/JUK, cleavage-Caspase-7, and p-TAK1, but increased the expression levels of p-53 and cleavage-PARP in AGS cells compared to shCtrl group. We demonstrated that IARS2 knockdown inhibits proliferation, suppresses colony formation, and causes cell cycle arrest in AGS cells. We also found that IARS2 regulates key molecules of cell apoptosis-related signaling pathway.

Entities:  

Keywords:  Cell cycle; Gastric cancer; IARS2

Mesh:

Substances:

Year:  2017        PMID: 29071539     DOI: 10.1007/s11010-017-3213-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

Review 1.  Aminoacyl-tRNA synthetase complexes: beyond translation.

Authors:  Sang Won Lee; Byeong Hoon Cho; Sang Gyu Park; Sunghoon Kim
Journal:  J Cell Sci       Date:  2004-08-01       Impact factor: 5.285

2.  Expression of IARS2 gene in colon cancer and effect of its knockdown on biological behavior of RKO cells.

Authors:  Ling Zhong; Yi Zhang; Jing-Yu Yang; Liang-Fa Xiong; Tao Shen; Ya-Lian Sa; Yi-Ming O'Yang; Si-Hui Zhao; Jia-Yong Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Loss of caspase-2, -6 and -7 expression in gastric cancers.

Authors:  Nam Jin Yoo; Jong Woo Lee; Yun Ju Kim; Young Hwa Soung; Su Young Kim; Suk Woo Nam; Won Sang Park; Jung Young Lee; Sug Hyung Lee
Journal:  APMIS       Date:  2004-06       Impact factor: 3.205

4.  Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.

Authors:  Veli-Matti Wasenius; Samuli Hemmer; Eeva Kettunen; Sakari Knuutila; Kaarle Franssila; Heikki Joensuu
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

5.  NB1011 induces Ser15 phosphorylation of p53 and activates the G2/M checkpoint.

Authors:  Ryan W Dellinger; Patricia L Karjian; Saskia T C Neuteboom
Journal:  Anticancer Drugs       Date:  2003-07       Impact factor: 2.248

6.  IARS2 silencing induces non-small cell lung cancer cells proliferation inhibition, cell cycle arrest and promotes cell apoptosis.

Authors:  J Yin; W Liu; R Li; J Liu; Y Zhang; W Tang; K Wang
Journal:  Neoplasma       Date:  2016       Impact factor: 2.575

7.  TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers.

Authors:  C Freudlsperger; Y Bian; S Contag Wise; J Burnett; J Coupar; X Yang; Z Chen; C Van Waes
Journal:  Oncogene       Date:  2012-05-28       Impact factor: 9.867

8.  Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancer.

Authors:  Yijun Wu; Qi Li; Xinhui Zhou; Jiren Yu; Yunchuan Mu; Stefan Munker; Chengfu Xu; Zhe Shen; Roman Müllenbach; Yan Liu; Li Li; Norbert Gretz; Derek Zieker; Jun Li; Kouichi Matsuzaki; Youming Li; Steven Dooley; Honglei Weng
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

9.  Mouse Genome Database (MGD)-2017: community knowledge resource for the laboratory mouse.

Authors:  Judith A Blake; Janan T Eppig; James A Kadin; Joel E Richardson; Cynthia L Smith; Carol J Bult
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

10.  Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma.

Authors:  Yong-Wan Kim; Changhyuk Kwon; Juinn-Lin Liu; Se Hoon Kim; Sunghoon Kim
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

View more
  5 in total

1.  Lentivirus-induced knockdown of IARS2 expression inhibits the proliferation and promotes the apoptosis of human osteosarcoma cells.

Authors:  Qi Liu; Feng Lin
Journal:  Oncol Lett       Date:  2022-06-15       Impact factor: 3.111

2.  RNAi-mediated IARS2 knockdown inhibits proliferation and promotes apoptosis in human melanoma A375 cells.

Authors:  Dongmei Ma; Song Li; Xiaojuan Nie; Lamei Chen; Nan Chen; Dongsheng Hou; Xiuhong Liu; Binbin Gao
Journal:  Oncol Lett       Date:  2020-05-29       Impact factor: 2.967

3.  Knockdown of IARS2 Inhibited Proliferation of Acute Myeloid Leukemia Cells by Regulating p53/p21/PCNA/eIF4E Pathway.

Authors:  Hong Li; Yaning Tian; Xiang Li; Bin Wang; Dongzhi Zhai; Yingying Bai; Changhu Dong; Xu Chao
Journal:  Oncol Res       Date:  2019-03-04       Impact factor: 5.574

Review 4.  Roles of Aminoacyl-tRNA Synthetases in Cancer.

Authors:  Zheng Zhou; Bao Sun; Anzheng Nie; Dongsheng Yu; Meng Bian
Journal:  Front Cell Dev Biol       Date:  2020-11-27

5.  Identification of an amino acid metabolism-associated gene signature predicting the prognosis and immune therapy response of clear cell renal cell carcinoma.

Authors:  Fan Zhang; Junyu Lin; Daiwen Zhu; Yongquan Tang; Yiping Lu; Zhihong Liu; Xianding Wang
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.